Evidence map›Paper›PMID 38771039›Full record

ArticleJournal of bacteriology2024

Group B

Nadine Vollmuth, Bailey E Bridgers, Madelyn L Armstrong, Jacob F Wood, Abigail R Gildea, Eric R Espinal, Thomas A Hooven, Giulia Barbieri, Alexander J Westermann, Till Sauerwein and 3 more

Abstract read
In one paragraph

Article in Journal of bacteriology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. CRISPR interference in aJournal of bacteriology · 2026
    Article
  2. Review
  3. Article
  4. Microbiology resource announcements · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nadine Vollmuth *Department of Biological Sciences, University of Alabama, Tuscaloosa, Alabama, USA.ORCID 0000-0002-1003-4410
Bailey E Bridgers *Department of Biological Sciences, University of Alabama, Tuscaloosa, Alabama, USA.
Madelyn L ArmstrongDepartment of Biological Sciences, University of Alabama, Tuscaloosa, Alabama, USA.
Jacob F WoodDepartment of Biological Sciences, University of Alabama, Tuscaloosa, Alabama, USA.
Abigail R GildeaDepartment of Biological Sciences, University of Alabama, Tuscaloosa, Alabama, USA.
Eric R EspinalDepartment of Biological Sciences, University of Alabama, Tuscaloosa, Alabama, USA.
Thomas A HoovenDepartment of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.ORCID 0000-0003-1959-186X
Giulia BarbieriDepartment of Biology and Biotechnology, University of Pavia, Pavia, Italy.ORCID 0000-0001-6622-5876
Alexander J WestermannInstitute of Molecular Infection Biology (IMIB), University of Wuerzburg, Wuerzburg, Germany.
Till SauerweinInstitute of Molecular Infection Biology (IMIB), University of Wuerzburg, Wuerzburg, Germany.
Konrad U FoerstnerInstitute of Molecular Infection Biology (IMIB), University of Wuerzburg, Wuerzburg, Germany.
Alexandra Schubert-UnkmeirInstitute for Hygiene and Microbiology, University of Wuerzburg, Wuerzburg, Germany.ORCID 0000-0003-0870-7505
Brandon J KimDepartment of Biological Sciences, University of Alabama, Tuscaloosa, Alabama, USA.ORCID 0000-0003-0476-8028

Funding

A Rationally Targeted Approach to Preventing GBS InfectionK08AI132555 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HOOVEN, THOMAS A · 2018 to 2021
$769k
Genome-wide assessment of Group B Streptococcus fitness and virulenceR21AI147511 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HOOVEN, THOMAS A, RATNER, ADAM JONATHAN · 2020 to 2021
$489k
Impairment of the cerebral vasculature during bacterial meningitisR15NS131921 · NINDS · UNIVERSITY OF ALABAMA IN TUSCALOOSA · PI CORRELL, ROBERT NATHAN · 2023 to 2023
$447k
Alexander von Humboldt-Stiftung (AvH)HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R15NS131921NIAID NIH HHS K08 AI132555NIAID NIH HHS R21 AI147511NINDS NIH HHS R15 NS131921
6 · The paper itself

Abstract

Bacterial meningitis is a life-threatening infection of the central nervous system (CNS) that occurs when bacteria are able to cross the blood-brain barrier (BBB) or the meningeal-cerebrospinal fluid barrier (mBCSFB). The BBB and mBCSFB comprise highly specialized brain endothelial cells (BECs) that typically restrict pathogen entry. Group B IMPORTANCE: Group B

Indexed as

BrainEndothelial CellsStreptococcus agalactiaeTranscriptomeBacterial ProteinsBlood-Brain BarrierGene Expression Regulation, BacterialHumansMeningitis, BacterialStreptococcal InfectionsVirulenceVirulence FactorsBacterial ProteinsVirulence Factorsblood–brain barrierbrain endothelial cellsGroup B StreptococcusStreptococcus agalactiaetranscriptome

Identifiers

PMID38771039
PMCPMC11332166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.